Samuel Whiting

Insider Reports History

Location
South San Francisco, CA
Signature
/s/ Nicholas Maestas, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Samuel Whiting:

Company Role Class Num Shares Value Price $ Report Date Ownership
Tempest Therapeutics, Inc. Chief Medical Officer Common Stock 9,573 $20,390 $2.13 02 Jul 2024 Direct
Tempest Therapeutics, Inc. Chief Medical Officer Employee Stock Option (right to buy) 270,000 02 Jan 2025 Direct

Insider Reports Filed by Samuel Whiting

Symbol Company Period Transactions Value $ Form Type Role Filing Time
TPST Tempest Therapeutics, Inc. 02 Jan 2025 1 $0 4 Chief Medical Officer 06 Jan 2025, 17:00
TPST Tempest Therapeutics, Inc. 02 Jul 2024 1 +$9,951 4 Chief Medical Officer 03 Jul 2024, 19:35
TPST Tempest Therapeutics, Inc. 03 Jan 2024 1 $0 4 Chief Medical Officer 05 Jan 2024, 16:40
TPST Tempest Therapeutics, Inc. 11 Oct 2023 1 $0 4 Chief Medical Officer 13 Oct 2023, 16:39
TPST Tempest Therapeutics, Inc. 03 Jan 2023 1 $0 4 Chief Medical Officer 05 Jan 2023, 19:02
TPST Tempest Therapeutics, Inc. 22 Jun 2022 1 $0 4 Chief Medical Officer 22 Jun 2022, 16:32
TPST Tempest Therapeutics, Inc. 06 Jan 2022 1 +$8,168 4 Chief Medical Officer 10 Jan 2022, 17:37
TPST Tempest Therapeutics, Inc. 04 Jan 2022 1 $0 4 Chief Medical Officer 06 Jan 2022, 18:25
TPST Millendo Therapeutics, Inc. 25 Jun 2021 4 $0 4 Chief Medical Officer 30 Jun 2021, 16:16
TPST Millendo Therapeutics, Inc. 25 Jun 2021 0 $0 3 Chief Medical Officer 30 Jun 2021, 16:10